Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked ...

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for type 2 diabetes and weight loss. Medications such as Ozempic, Wegovy, Mounjaro ...

Popular weight loss drugs like Ozempic and Mounjaro have been linked to serious eye conditions and vision loss. GLP-1 medications, which were initially used to treat diabetes, have become more popular ...

Two complement inhibitors tied to increased risk of wet AMD, but data called suspect ...

A small percentage of patients on injectable weight loss drugs such as Ozempic and Wegovy experienced permanent vision loss, according to a new study. The report, published Thursday in the medical ...

Share on Pinterest Research on GLP-1 drugs and eye health has been inconsistent, but experts say the risk of serious eye disease is generally low. Getty Images/Hiraman Studies have linked GLP-1 ...

Headlines warning about “Ozempic blindness” may be frightening to the millions of people taking a GLP-1 drug to treat Type 2 diabetes or for weight loss. It's not an official diagnosis, but an ...

New research suggests that weight-loss drugs can help prevent vision loss as patients age, but there’s a major caveat. GLP-1 weight-loss drugs linked to reduced risk of age-related macular ...

In the glittering world of celebrity-endorsed weight loss transformations and viral before-and-after photos, a darker narrative is emerging from the shadows of medical journals. The newest generation ...

Ozempic is often prescribed to people with diabetes. Some of Ozempic’s side effects affecting vision may be due to having low blood sugar levels. Once the blood sugar improves, these side effects tend ...

A former Ironman triathlete says his eye problems led to a shocking stage 4 lung cancer diagnosis, but a series of targeted ...

The debate over whether GLP-1 medications raise the risk of eye conditions that could lead to vision loss continues. Scientists have been closely studying this association as more people turn to these ...